greeksoup/ stock research

Hims & Hers Health (HIMS) Q3 FY2023 earnings: revenue $227 million, up 56.5% on the year

Hims & Hers Health, Inc. (HIMS) reported revenue of $227 million for Q3 FY2023, the quarter ended 30 September 2023, up 56.5% on the same quarter a year earlier. Net income was -$8 million, and diluted earnings per share $-0.04. The figures are the company's own, from the 10-Q it filed with the SEC on 6 November 2023.

Revenue$227 millionup 56.5%
Net income-$8 million
Diluted EPS$-0.04
QuarterQ3 FY2023ended 30 September 2023

The quarter, against the one before and a year earlier

LineQ3 FY2023Quarter beforeA year earlierChange on the year
Revenue227n/an/an/a
Cost of revenue39.4n/an/an/a
Gross profit187n/an/an/a
Gross margin82.6%n/an/a
Operating income-8.6n/an/an/a
Operating margin-3.8%n/an/a
Pre-tax income-6.9n/an/an/a
Income tax0.7n/an/an/a
Net income-7.6n/an/an/a
Net margin-3.3%n/an/a
Diluted EPS-$0.04n/an/an/a
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow and capital returned

LineQ3 FY2023Quarter beforeA year earlierChange on the year
Operating cash flow25.2n/an/an/a
Cash from investing-31.1n/an/an/a
Cash from financing-1.6n/an/an/a
Depreciation and amortisation2.4n/an/an/a
Share-based compensation17.3n/an/an/a
Buybacks0.0n/an/an/a
Diluted shares, weighted210mn/an/an/a

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet at quarter end

LineQ3 FY2023Quarter beforeA year earlierChange on the year
Shareholders' equity329n/an/an/a
Operating lease liabilities2.8n/an/an/a
Other liabilities82.5n/an/an/a
Total liabilities and equity414n/an/an/a
Goodwill111n/an/an/a
Intangible assets19.3n/an/an/a
Investments155n/an/an/a
Cash and equivalents58.0n/an/an/a
Inventory22.0n/an/an/a
Other assets49.2n/an/an/a
Total assets414n/an/an/a

Quarterly results, the last 12 quarters

Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026
Revenue227247278316402481586545599618608753
Cost of revenue39.442.649.159.083.7112155129157173211272
Gross profit187204229257318370431416442444397481
Gross margin83%83%82%81%79%77%73%76%74%72%65%64%
Operating income-8.6-0.49.911.022.418.657.926.711.89.2-78.3-97.2
Operating margin-4%-0%4%3%6%4%10%5%2%1%-13%-13%
Pre-tax income-6.92.212.413.423.622.360.532.912.218.4-102-92.6
Tax raten/a43%10%1%-220%-17%18%-29%-29%-12%n/an/a
Net income-7.61.211.113.375.626.049.542.515.820.6-92.1-86.3
Net margin-3%1%4%4%19%5%8%8%3%3%-15%-11%
Diluted EPS-$0.04$0.01$0.05$0.06$0.32$0.11$0.20$0.17$0.06$0.08-$0.40-$0.37
Operating cash flow25.222.025.853.685.386.4109-19.114961.389.4-35.9
Capital expendituren/an/a14.06.05.926.959.050.469.463.836.332.3
Free cash flown/an/a11.847.679.459.550.1-69.579.3-2.553.1-68.2
Buybacks0.02.028.119.930.05.00.00.09.580.5n/an/a
Filing10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS and diluted share count are from the company's results press release for that quarter, used where the release gives the same revenue and net income as the table. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Source

10-Q for the period ended 30 September 2023, filed 6 November 2023, accession 0001773751-23-000278: the filing on EDGAR. All of Hims & Hers Health, Inc.'s filings: EDGAR company page.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install